Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2350)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (23)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4746)
  2. Department of Medicine (4744)
  3. Center for Pancreatic Cancer Research (2313)
  4. Surgery (1066)
  5. Survivorship Research (1014)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (221)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (148)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (321)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4746)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Response to anti-PD-1 in microsatellite-stable colorectal cancer: A STAT need
    Editorial

    Nusrat, M.
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Serum alpha-fetoprotein levels and clinical outcomes in the phase III CELESTIAL study of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma
    Journal Article

    Kelley, R. K.; Meyer, T.; Rimassa, L.; Merle, P.; Park, J. W.; Yau, T.; Chan, S. L.; Blanc, J. F.; Tam, V. C.; Tran, A.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • The aged microenvironment of melanoma feeds escape from targeted therapy
    Editorial

    Montal, E. D.; White, R. M.
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Low immunogenicity and favorable safety seen with novel regimen of tremelimumab (T) plus durvalumab (D) in patients (pts) with unresectable hepatocellular carcinoma (uHCC)
    Meeting Abstract

    Kelley, R. K.; Negro, A.; Chen, C.; Ali, S.; Standifer, N.; Watras, M.; Evans, B.; Abou-Alfa, G. K.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • SPOTLIGHT: Phase III study of zolbetuximab + mFOLFOX6 versus placebo + mFOLFOX6 in first-line Claudin18.2(+)/HER2(-) advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)
    Meeting Abstract

    Shitara, K.; Al-Batran, S. E.; Bang, Y. J.; Catenacci, D.; Enzinger, P. C.; Ilson, D. H.; Kim, S.; Lordick, F.; Shah, M. A.; van Cutsem, E.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Pembrolizumab vs chemotherapy in patients with microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: Asia subgroup results of the phase III KEYNOTE-177 study
    Meeting Abstract

    Yoshino, T.; Kim, T. W.; Yong, W. P.; Shiu, K. K.; Vittrup Jensen, B.; Henrik Jensen, L; Smith, D.; Garcia-Carbonero, R.; Alcaide-Garcia, J.; Gibbs, P.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • GLOW: Phase III study of first-line zolbetuximab + CAPOX versus placebo + CAPOX in Claudin18.2(+)/HER2(-) advanced/metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)
    Meeting Abstract

    Xu, R. H.; Ajani, J. A.; Al-Batran, S. E.; Bang, Y. J.; Catenacci, D.; Enzinger, P. C.; Ilson, D. H.; Kim, S.; Lordick, F.; Shitara, K.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • A randomized, double-blind, phase III study of pembrolizumab plus chemotherapy as first-line therapy in patients with HER2-negative, advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: KEYNOTE-859
    Meeting Abstract

    Qin, S.; Tabernero, J.; van Cutsem, E.; Fuchs, C. S.; Janjigian, Y. Y.; Bhagia, P.; Li, K.; Adelberg, D.; Bang, Y. J.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Management of adverse events associated with encorafenib plus cetuximab in patients with BRAF V600E mutant metastatic colorectal cancer (BEACON CRC Study)
    Meeting Abstract

    Chiu, C. F.; Yeh, Y. M.; Yeh, K. H.; Desai, J.; Price, T. J.; Tebbutt, N.; Tabernero, J.; Velez, L.; Trevino, T. L.; Grothey, A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline
    Guidelines

    Gordan, J. D.; Kennedy, E. B.; Abou-Alfa, G. K.; Beg, M. S.; Brower, S. T.; Gade, T. P.; Goff, L.; Gupta, S.; Guy, J.; Harris, W. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save